<DOC>
	<DOCNO>NCT00443794</DOCNO>
	<brief_summary>STUDY TITLE A randomize double-blind control trial efficacy safety POLYCAP速 versus component subject age 45 80 year age least one additional cardiovascular risk factor . STUDY OBJECTIVES This study design assess efficacy safety POLYCAP速 , fix dose combinationcontaining 5 drug ( antiplatelet drug ; 3 blood pressure lower agent , beta blocker , ACE inhibitor , diuretic statin . STUDY DESIGN Randomized control double-blind trial POLYCAP速 versus component eight formulation . STUDY POPULATION Subjects 45 80 year age , least one additional CVD risk factor . INVESTIGATIONAL PRODUCTS Composition POLYCAP速 comparators FOLLOW UP The total duration follow 4 month , start study medication.. Subjects take study medication 3 month . There final follow visit 1 month stop study medication . There five follow visit , first 7 - 10 day start study medication thereafter monthly visit 4 month . Subjects take study medication prior enrolment one additional visit define wash enrolment . OUTCOME MEASURES Mean difference change BP , LDL urinary thromboxane end three month period . STATISTICAL ISSUES Non-inferiority evaluation POLYCAP modifying BP , lipids platelet activity [ measure urinary thromboxane ] compare different component eight different formulation .</brief_summary>
	<brief_title>The Indian POLYCAP Study ( TIPS )</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<criteria>Age 45 80 year At least one follow CVD risk factor : Stable type 2 diabetes mellitus Hypertension Current smoker A waist hip ratio &gt; 0.85 woman &gt; 0.9 men Elevated lipid . Informed consent . On study medication , Uncontrolled blood pressure , Symptomatic hypotension , Any clear indication contraindication use study medication , History coronary/cerebrovascular event , Pregnancy lactate woman childbearing potential inadequate contraception / inability attend follow visit .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>POLYCAP , Primary Prevention , CVD</keyword>
</DOC>